Altimmune (ALT) Receivables (2010 - 2026)
Altimmune's Receivables came in at $3.34 million for Q2 2026, up 940.8% from $321,000 a year earlier and up 100.7% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Altimmune's Receivables was $1.22 million, up 124.1% from FY2024.
- Receivables carries a three-year compound annual growth rate of 91.7% (FY2022 to FY2025).
- Going back by year, Receivables was $544,000 in FY2024 (-51.0%), $1.11 million in FY2023 (+542.2%) and $173,000 in FY2022.
- The Q2 2026 figure represents the highest quarterly Receivables since Q4 2013.
- Year-over-year, Receivables has increased for four consecutive quarters, with growth averaging 197.2% over the last seven quarters.
- The fastest year-over-year change in Receivables over five years came in Q2 2026 (growth of 940.8%), and the weakest in Q4 2024 (a decline of 51.0%).
- Business Quant data shows ALT's Receivables at $1.67 million (Q1 2026), $1.22 million (Q4 2025) and $845,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Altimmune | 418.18 Mn | -724.05 Mn | - | 3.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.34 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | 321,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 544,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 173,000.00 |
| Mar 31, 2017 | 1.80 Mn |
| Dec 31, 2014 | 697,431.00 |
| Dec 31, 2013 | 5.80 Mn |
| Dec 31, 2011 | 7.90 Mn |
| Sep 30, 2011 | 6.38 Mn |
| Jun 30, 2011 | 7.35 Mn |
| Dec 31, 2010 | 9.68 Mn |
API Access
Altimmune Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();